Clinical Trials Browser

Recurrence × ruxolitinib × 90 days × Clear all

Lymphoma, Recurrence

Recurrence, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Leukemia, Large Granular Lymphocytic

Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Thrombocythemia, Essential, Primary Myelofibrosis

Clinical Trials